It gives us great pleasure to present the annual 13th edition of the International Symposium on Neuropsychiatry & VIH. We have been organizing this meeting during the last 12 years with an enormous success due t he high level of our speakers and attendees, the high interest and participation in the workshops and the high value of some time for networking and interpersonal meeting. This used to happen in one of the most beautiful places in the world, which is the of the city of Barcelona.
Since its first edition, this Symposium is aimed at those health professionals who have healthcare or scientific interest in promoting neuropsychological and neuropsychiatric health of people with HIV. It has had an eminently practical character designed to the detection and management of the most frequent problems such as depression or neurocognitive deterioration, the knowledge of the neuropsychological effects of the antiretrovirals and of the adverse effects of psychopharmacological treatments and the consideration of the more outstanding interactions between both groups of medicines. This Symposium has consolidated as a discussion forum about the latest researches on central nervous system aspects affected by HIV. Attendees had been able to learn about some very useful basic notions for their daily clinical practice to improve the management of psychiatric and neuropsychological problems in their patients.
Due to the uncertainty caused by the Covid-19 in Spain and around the world, we have been forced to postpone the date of this year’s edition, and we have had to adapt the format and the content as well. We decided to modify the format from a standard face-to-face meeting to a virtual one. Instead of a meeting of one and a half days, the programme is distributed into 5 shorter webinars (3 main sessions and 2 round tables, all 90 minutes long) to be developed during 2 weeks at the end of October and starting November 2020. We also felt that we needed to update the symposium content including references to the SARS-CoV-2 pandemic. We considered including the perspective of the impact of the SARS-CoV-2 on people with HIV / AIDS, choosing topics that could be of special interest for HIV professionals.
Therefore, the 13th International Symposium on Neuropsychiatry & VIH will present new knowledge and research in the field of HIV and/or SARS-CoV-2 effects on CNS, as well as about the psychological and psychiatric impact of the lockdown and the socio-economic consequences of the pandemic in people with HIV.
In any case, all these changes will not change the aim of this annual Symposium and we are sure that it will maintain the interest and high level of previous editions.
We’ll be very thankful to you if you share this information with all of those who can be interested in it.
We look forward to your active participation.
See you in October!
Jordi Blanch y Esteban Martínez